Stimulation of prostacyclin release by endothelial ATP receptors requires activation of protein kinase C and tyrosine kinases.
Brown
C A
CA
Department of Cell Physiology and Pharmacology, University of Leicester.
Bowden
A
A
Patel
V
V
Boarder
M R
MR
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D015153:Blotting, Western; D002417:Cattle; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D011464:Epoprostenol / Q000378:metabolism*; D019000:Phosphotyrosine / Q000032:analysis; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2 / Q000502:physiology*; D013873:Thionucleotides / Q000494:pharmacology; D014544:Uridine Triphosphate / Q000494:pharmacology
D004791:Enzyme Inhibitors; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2; D013873:Thionucleotides; D019000:Phosphotyrosine; D015121:6-Ketoprostaglandin F1 alpha; D000255:Adenosine Triphosphate; D011464:Epoprostenol; D011505:Protein-Tyrosine Kinases; D011493:Protein Kinase C; D014544:Uridine Triphosphate; C008501:2-methylthio-ATP